1997

116.- Charco R, Margarit C y Allende H. "Rechazo e inmunosupresión". En, Trasplante Hepático . Hepatología Gastroenterología 1996;19:419-426
117.- Charco R, Jaurrieta E, Vargas V, Balsells J, Murio JE, Lázaro JL, Margarit C and J. Martorell. Relevance of positive lymphocytotoxic crossmatch and immunosuppressive regimens in the outcome of liver transplants. Transplant Proc 1997;29:461-62
118.- Bilbao I., Hidalgo E, Lázaro JL, Charco R, Balsells J, Murio JE, Cuadrado TF, Margarit C. Risk factors for severe ischemic lesion after liver transplantion. Transplant Proc 1997; 29:368-70
119.- Lázaro JL , Revhaug A, Murio JE., Balsells J., Charco R., Hidalgo E, Mora A, Cortés C, and Margarit C. Haemodynamic study of the Piggy-back technique in liver transplantation. Transplant Proc 1997;29:2851-52
120.- Martinez Ibáñez V , Vilchez R , Ortega J , Iglesias J, Allende H, Margarit C, Matamoros N and Español T. Relapse of sclerosing cholangitis after liver transplantation in children with hyper-IgM syndrome. Transplant Proc 1997;29:432-433
121.- Gavaldá J, Otero J, Murio JE., Vargas V, Rosselló J, Galicó I, Margarit C,
Pahissa A. Two grams dayly of oral acyclovir reduces the incidence of cytomegalovirus disease in CMV-seropositive liver transplant recipients. Transplant Int 1997;10:462-465


web realitzada per MediTecnologia
darrera actualització: 11/02/2005